Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q21099552> ?p ?o }
Showing triples 1 to 28 of
28
with 100 triples per page.
- Q21099552 subject Q8256334.
- Q21099552 subject Q8256374.
- Q21099552 subject Q8431759.
- Q21099552 abstract "Rigosertib (ON-01910 sodium salt, with Estybon as trade name) is a synthetic benzyl styryl sulfone that is in phase III clinical trials as an anti-cancer agent. Its geometrical isomer (Z)-ON 01910·Na has less cytotoxicity on cancer cells.".
- Q21099552 iupacName "2‐[(2‐Methoxy‐5‐{[(E)‐2‐(2,4,6‐trimethoxyphenyl)ethenesulfonyl]methyl}phenyl)amino]acetic acid".
- Q21099552 thumbnail Rigosertib.svg?width=300.
- Q21099552 wikiPageWikiLink Q12078.
- Q21099552 wikiPageWikiLink Q1502169.
- Q21099552 wikiPageWikiLink Q18030593.
- Q21099552 wikiPageWikiLink Q188941.
- Q21099552 wikiPageWikiLink Q283611.
- Q21099552 wikiPageWikiLink Q286779.
- Q21099552 wikiPageWikiLink Q423725.
- Q21099552 wikiPageWikiLink Q7180990.
- Q21099552 wikiPageWikiLink Q8256334.
- Q21099552 wikiPageWikiLink Q8256374.
- Q21099552 wikiPageWikiLink Q8431759.
- Q21099552 iupacname "2".
- Q21099552 name "Rigosertib".
- Q21099552 type ChemicalCompound.
- Q21099552 type ChemicalSubstance.
- Q21099552 type ChemicalObject.
- Q21099552 type Thing.
- Q21099552 type Q11173.
- Q21099552 comment "Rigosertib (ON-01910 sodium salt, with Estybon as trade name) is a synthetic benzyl styryl sulfone that is in phase III clinical trials as an anti-cancer agent. Its geometrical isomer (Z)-ON 01910·Na has less cytotoxicity on cancer cells.".
- Q21099552 label "Rigosertib".
- Q21099552 depiction Rigosertib.svg.
- Q21099552 name "Rigosertib".